Join Us!! Fourth COVID-19 Townhall Update with Lt. Col. Matthew T. Swingholm!
Image for the MHS and Military OneSource Town Hall: The Critical Need for Blood Donations
Please join us for the Fourth Military Health System and Military OneSource COVID-19 Townhall!
April 28, 2021 at 2:00 p.m. ET
Lt. Col. Matthew T. Swingholm, Armed Services Blood Program, will be providing information about the current state of the blood program, and the impact of COVID-19 on blood donations. He'll also discuss who can donate to the blood program, and how soon after receiving the vaccine or COVID-19 you can donate blood.
Please also join us on the following dates for additional COVID-19 Townhall updates!
Military OneSource will host DHA experts, allowing them the opportunity to address various topics related to COVID-19, such as:
- Available vaccines and their distribution, safety, and efficacy
- Scheduling appointments within the Military Health System
- Guidance on continued protective measures to slow the spread of the virus
- Personal/real positive outcomes from vaccines
Join us here on the following dates as well:
- May 12, 2021
- May 25, 2021
- June 8, 2021
- June 22, 2021
Get the latest facts about the virus and DHA's response to it. We look forward to seeing you here!
You also may be interested in...
Policy
Aug 18, 2022
.PDF |
156.56 KB
Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.
- Identification #: 22-006
- Type: Memorandums
Policy
Jan 7, 2022
This instruction assign responsibilities, and prescribe procedures to carry out the responsibilities of the Armed Services Blood Program (ASBP) during peacetime, contingency, and wartime operations.
- Identification #: DoD Instruction 6480.04
- Type: Instructions
Policy
Nov 3, 2021
.PDF |
1.43 MB
This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.
- Identification #: 21-004
- Type: Memorandums
Policy
Mar 25, 2021
.PDF |
161.81 KB
Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy
- Identification #: N/A
- Type: Memorandums
Policy
Mar 25, 2021
.PDF |
436.92 KB
Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.
- Identification #: 20-003
- Type: Memorandums
Policy
Dec 31, 2020
.PDF |
129.54 KB
This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.
- Identification #: N/A
- Type: Memorandums
Policy
Dec 17, 2020
.PDF |
574.09 KB
This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.
- Identification #: N/A
- Type: Memorandums
Policy
Dec 7, 2020
This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.
- Identification #: N/A
- Type: Memorandums
Policy
Nov 13, 2020
.PDF |
148.27 KB
Upon transfer, the Director, DHA, will assume responsibility for ensuring all Armed Services Blood Program (ASBP) activities are FDA-compliant.
- Identification #: N/A
- Type: Memorandums
Policy
Nov 3, 2020
.PDF |
846.31 KB
Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic
- Identification #: 3020.01
- Type: Administrative Instructions
Policy
May 13, 2020
.PDF |
354.70 KB
The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum ...
- Identification #: 20-003
- Type: Memorandums
Policy
Aug 7, 2018
.PDF |
258.78 KB
On July 9, 2014, the Deputy Secretary of Defense approved the realignment of medical Department of Defense (DoD) Executive Agent (EA) organizations to the Defense Health Agency (DHA), including the Armed Services Blood Program Office (ASBPO) and DoD Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Prevention Program (DHAPP).
- Identification #: N/A
- Type: Memorandums
Policy
Feb 3, 2016
.PDF |
314.22 KB
This guidance contains information about the potential for transfusion-transmitted Zika infection; recommends facilitating donor self-deferral of 28 days after travel to Mexico, the Caribbean, Central America and South America.
- Identification #: BPL 16-2
- Type: Memorandums
Policy
May 27, 2014
.PDF |
848.22 KB
Transition of Executive Agent Responsibilities to the DHA
- Identification #: N/A
- Type: Memorandums
Policy
Oct 3, 2013
This directive designates the Secretary of the Army as the DoD Executive Agent for the Armed Services Blood Program Office (ASBPO) (Reference (h)), who exercises this authority through the Surgeon General of the Army, in accordance with DoDD 5101.1 (Reference (d)).
- Identification #: DoD Directive 6000.12E
- Type: Directives
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: July 11, 2023